Versant Capital Management’s BioLife Solutions BLFS Stock Holding History

Versant Capital Management’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.1K	Buy	498 +42	+9%	+$982	﹤0.01%	2106
2026 Q1	$8.7K	Sell	456 -370	-45%	-$8.18K	﹤0.01%	2192
2025 Q4	$20K	Hold	826	–	–	﹤0.01%	1642
2025 Q3	$21.1K	Sell	826 -484	-37%	-$11.5K	﹤0.01%	1552
2025 Q2	$28.2K	Buy	1,310 +1,170	+836%	+$26.4K	﹤0.01%	1321
2025 Q1	$3.2K	Buy	140 +44	+46%	+$1.16K	﹤0.01%	2185
2024 Q4	$2.49K	Buy	96 +15	+19%	+$373	﹤0.01%	2003
2024 Q3	$2.03K	Buy	+81	New	+$1.91K	﹤0.01%	1557

Other funds holding BLFS

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Isthmus Partners Madison, Wisconsin $1.03B AUM 22.86% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

KPP

Kings Path Partners Sugar Land, Texas $376M AUM 19% 1-Year Est. Return

NAM

NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

1IA

1620 Investment Advisors Plymouth, Massachusetts $161M AUM 30.15% 1-Year Est. Return

Versant Capital Management's BLFS Position: Q2 2026 in Review

Versant Capital Management increased its BioLife Solutions (BLFS) stake by 9.2% in Q2 2026, buying an estimated $982 and bringing the position to 498 shares worth $14.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2106.

Versant Capital Management first reported a position in BLFS in Q3 2024 and has held it in 8 quarters since. The position peaked at $28.2K in Q2 2025. 18 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

Versant Capital Management held 498 shares of BioLife Solutions worth $14.1K as of Q2 2026.
Versant Capital Management bought 42 BioLife Solutions shares in Q2 2026, an estimated $982.
BioLife Solutions made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2106 holding.
Versant Capital Management first reported a position in BioLife Solutions in Q3 2024 and has held it in 8 quarters since.
Versant Capital Management's BioLife Solutions position peaked at $28.2K in Q2 2025.
18 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.